Victory Capital Management
GRNA

Victory Capital Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Victory Capital Management’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,386
Closed -$23K – 2809
2022
Q2 		$23K Sell
10,386
-38
-0.4% -$263 ﹤0.01% 2605
2022
Q1 		$85K Buy
+10,424
New +$93.4K ﹤0.01% 2543

Other funds holding GRNA

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CGC
Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Victory Capital Management's GRNA Position: Q3 2022 in Review

Victory Capital Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2022, closing a stake of 10,386 shares — an estimated $23K sold.

Victory Capital Management first reported a position in GRNA in Q1 2022 and held it in 2 quarters. The position peaked at $85K in Q1 2022. 57 funds tracked by Wall St. Rank hold GRNA as of Q3 2022.

  • Victory Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 10,386 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2022, an estimated $23K.
  • Victory Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2022 and held it in 2 quarters.
  • Victory Capital Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $85K in Q1 2022.
  • 57 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.